Plasma cell myeloma. An interpretive review
作者： D. E. Bergsagel
DOI: 10.1002/1097-0142(197212)30:6<1588::AID-CNCR2820300626>3.0.CO;2-Y
关键词:
摘要:
sci-hub.se 参考文章(32)
JAMES F. HOLLAND, HENRY HOSLEY, CAROL SCHARLAU, PAUL P. CARBONE, EMIL FREI, CLYDE O. BRINDLEY, THOMAS C. HALL, BRUCE I. SHNIDER, G. LENNARD GOLD, LOUIS LASAGNA, ALBERT H. OWENS, SHERWOOD P. MILLER, A Controlled Trial of Urethane Treatment in Multiple Myeloma Blood. ,vol. 27, pp. 328- 342 ,(1966) , 10.1182/BLOOD.V27.3.328.328
E. A. McCulloch, Makio Ogawa, Daniel E. Bergsagel, Differential effects of melphalan on mouse myeloma (adj.pc-5) And hemopoietic stem cells. Cancer Research. ,vol. 31, pp. 2116- 2119 ,(1971)
M Ogawa, D E Bergsagel, E A Culloch, Differential effects of chemotherapeutic agents on mouse myeloma and hemopoietic stem cells. Abstr. pp. 934- ,(1972)
Donald H. Cowan, Daniel E. Bergsagel, Richard Hasselback, Plasma cell myeloma: response of melphalan-resistant patients to high-dose intermittent cyclophosphamide Canadian Medical Association Journal. ,vol. 107, pp. 851- 855 ,(1972)
D. E. Bergsagel, An assessment of massive-dose chemotherapy of malignant disease Canadian Medical Association Journal. ,vol. 104, pp. 31- 36 ,(1971)
D. E. Bergsagel, F. A. Valeriote, Growth characteristics of a mouse plasma cell tumor Cancer Research. ,vol. 28, pp. 2187- 2196 ,(1968)
Daniel E. Bergsagel, K.M. Griffith, A. Haut, W.J. Stuckey, The treatment of plasma cell myeloma. Advances in Cancer Research. ,vol. 10, pp. 311- 359 ,(1967) , 10.1016/S0065-230X(08)60081-0
Mouse Myeloma Tumor Stem Cells: A Primary Cell Culture Assay Journal of the National Cancer Institute. ,vol. 46, pp. 411- 422 ,(1971) , 10.1093/JNCI/46.2.411
D. C. L. Fitzwilliams, Cancer of the breast BMJ. ,vol. 1, pp. 640- 640 ,(1937) , 10.1136/BMJ.1.3972.416
JAMES R. MCARTHUR, Melphalan and Myeloma Annals of Internal Medicine. ,vol. 72, pp. 665- 670 ,(1970) , 10.7326/0003-4819-72-5-665